Protocatechuic acid inhibits proliferation, migration and inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes
Source abstract
Abstract
Rheumatoid arthritis (RA) is a chronic joint inflammatory disease that is closely associated with dysregulation of fibroblast-like synoviocytes (FLSs). Protocatechuic acid (PCA), a phenolic compound of anthocyanins, has been proven to possess anti-inflammatory activity. However, the role of PCA in RA has not been investigated. In the present study, we aimed to explore the effects of PCA on the RA-FLSs. The results showed that PCA suppressed the proliferation, invasion, and migration of RA-FLSs in a dose-dependent manner. PCA treatment also inhibited the expressions of matrix metalloproteinase (MMP)-3 and MMP-13, as well as the secretion of inflammatory cytokines including TNF-α, IL-1β, IL-6 in RA-FLSs. Moreover, cell apoptosis of RA-FLSs was significantly induced by PCA treatment. PCA was found to repress the activation of NF-κB signalling, which was evidenced by the decreased expression of p-p65 and increased expression of IκBα. Furthermore, PCA significantly decreased the phosphorylation levels of Akt and mTOR in RA-FLSs. In conclusion, the results indicated that PCA exhibited an inhibitory effect on RA-FLSs via inhibiting the NF-κB and Akt/mTOR signalling pathways. These findings supported the concept that PCA might be a therapeutic agent for RA treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Toxin Mechanisms and Immunotoxins · Natural product bioactivities and synthesis · Rheumatoid Arthritis Research and Therapies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Rheumatology and Immunology, Huaihe Hospital, Henan University
References (28)
Show source-provided references
1. 10.1038/nature0166110.1038/nature01661 ↗
2. 10.1111/j.0105-2896.2009.00859.x10.1111/j.0105-2896.2009.00859.x ↗
3. Charles J, Britt H, Pan Y. Rheumatoid arthritis. Aust Fam Physician. 2013;42(11):765.
4. 10.1038/nrrheum.2012.19010.1038/nrrheum.2012.190 ↗
5. 10.1007/s00281-017-0631-310.1007/s00281-017-0631-3 ↗
6. 10.3402/fnr.v60.2962310.3402/fnr.v60.29623 ↗
7. 10.1515/JBCPP.2010.21.1.7910.1515/JBCPP.2010.21.1.79 ↗
8. Tanaka T, Kojima T, Suzui M, et al. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Cancer Res. 1993;53(17):3908–3913.
9. 10.1186/s41702-017-0018-z10.1186/s41702-017-0018-z ↗
10. 10.1016/j.biopha.2019.10861010.1016/j.biopha.2019.108610 ↗
11. 10.1016/j.jep.2011.03.00510.1016/j.jep.2011.03.005 ↗
12. 10.1186/ar11310.1186/ar113 ↗
13. 10.1007/BF0019718610.1007/BF00197186 ↗
14. 10.1002/art.178039110310.1002/art.1780391103 ↗
15. 10.1016/j.jep.2016.11.00910.1016/j.jep.2016.11.009 ↗
16. 10.1038/sj.onc.120995410.1038/sj.onc.1209954 ↗
17. 10.1016/S0092-8674(00)81694-310.1016/S0092-8674(00)81694-3 ↗
18. 10.1172/JCI1183010.1172/JCI11830 ↗
19. 10.1186/ar30010.1186/ar300 ↗
20. 10.1136/ard.2010.149104.810.1136/ard.2010.149104.8 ↗
21. 10.1093/labmed/lmx03310.1093/labmed/lmx033 ↗
22. 10.1016/j.joca.2006.04.00810.1016/j.joca.2006.04.008 ↗
23. 10.1186/ar332410.1186/ar3324 ↗
24. 10.1002/art.2506310.1002/art.25063 ↗
25. 10.1002/ptr.636410.1002/ptr.6364 ↗
26. 10.1016/j.biopha.2019.10887510.1016/j.biopha.2019.108875 ↗
27. 10.2119/molmed.2010.0004910.2119/molmed.2010.00049 ↗
28. 10.1016/j.intimp.2017.12.02410.1016/j.intimp.2017.12.024 ↗